Med. praxi. 2020;17(4):212-214 | DOI: 10.36290/med.2020.040

Influenza in the year 2020

MUDr. Jan Kynčl, Ph.D.1,2
1 Oddělení epidemiologie infekčních nemocí, Centrum epidemiologie a mikrobiologie, Státní zdravotní ústav, Praha
2 Ústav epidemiologie a biostatistiky, 3. lékařská fakulta Univerzity Karlovy, Praha

Influenza is an infectious disease causing annual epidemics. The disease affects all age groups of the population and its course is highly variable from mild to fatal. Serious disease course can occur not only in chronically ill people and the elderly, but also in healthy children or adults. Vaccination is the most important method of preventing influenza and its complications. Influenza vaccination is also important in preventing the occurrence of acute myocardial infarction or stroke, both in the chronically ill and in healthy people.

Keywords: influenza, morbidity, mortality, cardiovascular diseases, vaccination.

Published: September 25, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kynčl J. Influenza in the year 2020. Med. praxi. 2020;17(4):212-214. doi: 10.36290/med.2020.040.
Download citation

References

  1. Kyncl J, Prochazka B, Goddard NL, et al. A study of excess mortality during influenza epidemics in the Czech Republic, 1982-2000. Eur J Epidemiol 2005; 20: 365-371. Go to original source... Go to PubMed...
  2. Kyncl J, Prochazka B, Havlickova M, et al. Influenza attributable mortality in the Czech Republic. Poster P-488, Options IX for the control of influenza, Chicago, 2016.
  3. Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 2018 Mar 31; 391(10127): 1285-1300. Go to original source... Go to PubMed...
  4. Caini S, Schellevis F, El-Guerche Séblain C, et al. Important changes in the timing of influenza epidemics in the WHO European Region over the past 20 years: virological surveillance 1996 to 2016. Euro Surveill. 2018; 23(1): 17-00302. Go to original source... Go to PubMed...
  5. Kissling E, Nunes B, Robertson C, et al. I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination? Euro Surveill. 2016; 21(16). Go to original source...
  6. Gu XX, Plotkin SA, Edwards KM, et al. Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases. Clin Vaccine Immunol. 2017; 24(7): e00034-17. Go to original source... Go to PubMed...
  7. Ferdinands JM, Fry AM, Reynolds S, et al. Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15. Clin Infect Dis. 2017; 64(5): 544-550. Go to original source...
  8. Kwong JC, Schwartz KL, Campitelli MA, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med 2018; 378(4): 345-353. Go to original source...
  9. Warren-Gash C, Blackburn R, Whitaker H, et al. Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland. Eur Respir J. 2018; 51(3): 1701794. Go to original source... Go to PubMed...
  10. MacIntyre CR, Mahimbo A, Moa AM, et al. Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart 2016; 102(24): 1953-1956. Go to original source...
  11. Národní imunizační komise. Doporučený postup pro očkování proti sezónní chřipce. [online] [cit. 2020-07-30]. Dostupné na https://staryweb.mzcr.cz/Verejne/dokumenty/doporuceny-postup-pro-ockovani-proti-sezonni-chripce_5194_1985_5.html
  12. Paget J, Caini S, Cowling B, et al. The impact of influenza vaccination on the COVID-19 pandemic? Evidence and lessons for public health policies, Vaccine 2020; v tisku, dostupné online 19 August 2020. Go to original source...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.